|
1. Sarepta halts gene therapy treatment after 2nd death Full story
2. FDA OKs antibody to protect against RSV in infants Full story
3. Avoid the hidden cost of lab sell-offs. 5 data-driven reasons to keep it, here.
4. Eli Lilly updates single-dose vials of Zepbound on Lilly Direct Full story
5. Researchers challenge FDA's warning on a common epilepsy drug Full story
6. 6 specialty pharmacy billing gaps hospitals can't afford to ignore: here.
7. Experimental pill cuts LDL cholesterol nearly 30% in high-risk patients Full story
8. FDA debuts voucher program to speed drug approvals Full story
Becker's Learning Opportunities
9. Cancer centers are tapping AI to improve clinical trial matching. Learn more, here.
10. Flexible pharmacy staffing isn't a perk anymore — it's a must. Learn 5 ways to get it right: here.
11. 6 top RCM trends for 2025 — and what they mean for ASCs: here.
|
.png)
